[HTML] haematologica.org

[HTML][HTML] Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia …

P La Rosée, S Holm-Eriksen, H Konig, N Härtel… - …, 2008 - haematologica.org
Actual BCR-ABL kinase inhibition in vivo as determined by phospho-CRKL (pCRKL)
monitoring has been recognized as a prognostic parameter in patients with chronic …
被引用次数：51 相关文章

Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients …

P La Rosée, S Holm-Eriksen, H Konig, N Härtel… - …, 2008 - europepmc.org
Actual BCR-ABL kinase inhibition in vivo as determined by phospho-CRKL (pCRKL)
monitoring has been recognized as a prognostic parameter in patients with chronic …
[PDF] researchgate.net

[PDF][PDF] Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients …

P La Rosée, S Holm-Eriksen, H Konig, N Härtel… - …, 2008 - researchgate.net
Actual BCR-ABL kinase inhibition in vivo as determined by phospho-CRKL (pCRKL)
monitoring has been recognized as a prognostic parameter in patients with chronic …

[引用][C] Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients …

P LA ROSEE, S HOLM-ERIKSEN… - Haematologica …, 2008 - pascal-francis.inist.fr
Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic
myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib CNRS …

Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients …

P La Rosée, S Holm-Eriksen, H Konig… - …, 2008 - pubmed.ncbi.nlm.nih.gov
Actual BCR-ABL kinase inhibition in vivo as determined by phospho-CRKL (pCRKL)
monitoring has been recognized as a prognostic parameter in patients with chronic …
[HTML] haematologica.org

[HTML][HTML] Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia …

P La Rosée, S Holm-Eriksen, H Konig, N Härtel… - …, 2008 - haematologica.org
Actual BCR-ABL kinase inhibition in vivo as determined by phospho-CRKL (pCRKL)
monitoring has been recognized as a prognostic parameter in patients with chronic …
[PDF] psu.edu

[PDF][PDF] Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients …

P La Rosée, S Holm-Eriksen, H Konig, N Härtel, T Ernst… - haematologica, 2008 - Citeseer
Actual BCR-ABL kinase inhibition in vivo as determined by phospho-CRKL (pCRKL)
monitoring has been recognized as a prognostic parameter in patients with chronic …

[引用][C] Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients …

P LA ROSEE, S HOLM-ERIKSEN, H KONIG… - …, 2008 - Ferrata Storti Foundation